Day Trading Reports
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Day Trading Reports

Politics

Joe Biden diagnosed with ‘aggressive form’ of prostate cancer with metastasis to the bone

by admin May 19, 2025
May 19, 2025
Joe Biden diagnosed with ‘aggressive form’ of prostate cancer with metastasis to the bone

Former President Joe Biden’s office confirmed on Sunday that he is undergoing treatment for prostate cancer. 

‘Last week, President Joe Biden was seen for a new finding of a prostate nodule after experiencing increasing urinary symptoms,’ Biden’s team shared in a statement. ‘On Friday, he was diagnosed with prostate cancer, characterized by a Gleason score of 9 (Grade Group 5) with metastasis to the bone.’ 

‘While this represents a more aggressive form of the disease, the cancer appears to be hormone-sensitive which allows for effective management. The President and his family are reviewing treatment options with his physicians,’ the statement continued.

This is a developing story. Please check back for updates. 

Stepheny Price is a writer for Fox News Digital and Fox Business. She covers topics including missing persons, homicides, national crime cases, illegal immigration, and more. Story tips and ideas can be sent to stepheny.price@fox.com

This post appeared first on FOX NEWS

previous post
Rubio teases details of potential Trump, Putin in-person meeting after Russia-Ukraine ceasefire talks stall
next post
These dragon’s blood trees exist in only one place on Earth. Now their survival is under threat

Related Posts

Saudi defense minister secretly meets with Trump to...

July 4, 2025

Kristi Noem beats Senate confirmation hurdle, advancing to...

January 25, 2025

RFK Jr. sworn in as Health and Human...

February 14, 2025

Trump team holds ‘constructive’ face-to-face nuclear talks with...

April 13, 2025

First on Fox: House Republican campaign arm targets...

March 12, 2025

Patel, Gabbard to appear before Senate committees next...

January 25, 2025

GOP senators: Congress should vote on Trump’s potential...

May 9, 2025

Trump draws laughs when defining a ‘woman’ — until...

March 30, 2025

Inside the Situation Room, where Trump and his...

June 23, 2025

Trump proclaims that ‘wokeness is dead,’ calls to...

March 5, 2025

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Forum Energy Metals and Global Uranium Announce Exploration Update on Drill Targeting, Northwest Athabasca Project, Saskatchewan

      January 31, 2025
    • 2

      Mega M&A: Rio Tinto-Glencore Merger Sparks Chatter

      January 28, 2025
    • 3

      Excellent 90% recoveries at Cork Tree Well & Board Update

      February 17, 2025
    • 4

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 5

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 6

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: daytradingreports.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 daytradingreports.com | All Rights Reserved